LMAT
LeMaitre Vascular Inc
NASDAQ: LMAT · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$107.27
-4.57% today
Updated 2026-04-29
Market cap
$2.45B
P/E ratio
42.57
P/S ratio
9.82x
EPS (TTM)
$2.52
Dividend yield
0.71%
52W range
$77 – $118
Volume
0.2M
LeMaitre Vascular Inc (LMAT) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$107.27
12-Month target
$95.25
2030 Target
—
Intrinsic (DCF)
$59.48
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 23.10%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.